US › Healthcare

Champions Oncology Inc (CSBR)

US · Healthcare · Biotechnology

$4.70-1.88%

Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue

$15.2M

Revenue YoY

+8.8%

Net profit

$-426,000

EPS

$-0.03

EPS estimate

$-0.01

Net margin

-2.8%

EPS came in at -0.03 against a street estimate of -0.01 — a miss of 200.0%.

Key statistics

Market cap

$68.2M

Forward P/E

22.9

P/B

17.95

Book value

$0.28

EPS (TTM)

$-0.07

52-week high

$8.31

52-week low

$4.59

50-day MA

$5.05

200-day MA

$5.89

Beta

0.44

Analyst view

with an average price target of $12.00.

Shareholding

Insiders

26.33%

Institutions

48.71%

Largest institutional holders

Fund	Stake
Battery Management Corp	17.40%
NEA Management Company, LLC	12.31%
Vanguard Capital Management, LLC	2.17%
Tocqueville Asset Management L.P.	2.12%
Morgan Stanley - Brokerage Accounts	1.69%
Bank of America Corp	1.54%
Renaissance Technologies Corp	1.00%
BlackRock Inc	0.93%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Champions Oncology Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.